Moduretic
$ 59,00 – $ 249,00Price range: $ 59,00 through $ 249,00
Ofloxacin
$ 18,00 – $ 312,00Price range: $ 18,00 through $ 312,00
Obelit
$ 33,00 – $ 474,00Price range: $ 33,00 through $ 474,00
Obelit is an effective weight management medication specifically formulated to help individuals combat obesity and achieve a healthier body mass index. The primary active ingredient works by blocking a portion of dietary fat from being absorbed in the digestive tract, allowing it to pass through the system naturally. This treatment is designed to support long-term weight loss goals when paired with a calorie-conscious diet and regular physical activity. Beyond initial reduction, Obelit is instrumental in preventing weight regain, ensuring that users can maintain their progress over time. It provides a scientifically backed approach for those dedicated to improving their metabolic health and overall physical well-being.
Active substance: Orlistat
SKU:
Obelit
Category: Weight Loss
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Obelit belongs to a class of medications known as gastrointestinal lipase inhibitors. It is prescribed for weight management in individuals with obesity or overweight accompanied by weight-related medical conditions. The active ingredient, orlistat, functions locally within the digestive tract rather than acting on the central nervous system.
This medication is dispensed in accordance with applicable federal and state regulations. Proper clinical use requires combining the pharmacological therapy with a reduced-calorie, low-fat dietary regimen under appropriate medical oversight.
| Parameter | Details |
|---|---|
| Active ingredient (INN) | Orlistat |
| Therapeutic class | Gastrointestinal lipase inhibitor |
| Dosage form | Oral capsule |
| Route of administration | Oral |
| Primary purpose | Weight management and reduction of dietary fat absorption |
| Prescription status | Dispensed in accordance with applicable federal and state regulations |
How the drug works
The active pharmaceutical ingredient in Obelit is orlistat, a reversible inhibitor of gastrointestinal lipases. The therapeutic activity takes place within the lumen of the stomach and small intestine. Orlistat exerts its pharmacological effect by forming a covalent bond with the active serine site of gastric and pancreatic lipases. Inactivation of these enzymes renders them incapable of hydrolyzing dietary triglycerides into absorbable free fatty acids and monoglycerides.
Undigested triglycerides cannot be absorbed by the intestinal mucosa and are subsequently eliminated unchanged through the feces. At the standard therapeutic dosage of 120 mg taken three times daily, orlistat inhibits the absorption of approximately 30 percent of dietary fat. The action of the drug is localized entirely to the digestive tract and does not require systemic circulation to achieve its primary pharmacological effect.
Main uses
Obelit is indicated for weight management, including weight loss and maintenance of weight loss, when used in conjunction with a reduced-calorie diet. The medication is indicated for patients with obesity who present with an initial body mass index (BMI) of 30 kg/m² or greater. Clinical indication also extends to overweight patients with an initial BMI of 27 kg/m² or greater in the presence of concomitant risk factors, such as hypertension, type 2 diabetes mellitus, hyperlipidemia, or central obesity.
Therapy with Obelit aims to reduce weight-related health risks and improve metabolic parameters alongside structured diet and exercise programs. It is intended for long-term weight management under appropriate medical monitoring to ensure safety and evaluate therapeutic progress.
Dosing schedule
The standard recommended dosage of Obelit is one 120 mg capsule administered three times daily. Each capsule should be taken during or up to one hour after each main meal that contains fat. If a meal is missed or contains no dietary fat, the corresponding dose of Obelit should be omitted. Doses taken beyond one hour after a meal provide minimal inhibition of fat absorption.
The total daily caloric intake from fat should not exceed 30 percent of overall dietary intake. The daily intake of fat, carbohydrates, and protein should be evenly distributed across three main meals. Increasing the dosage above 120 mg three times daily has not been demonstrated to provide additional therapeutic benefit or increased weight loss.
What happens in the body
Systemic absorption of orlistat following oral administration is minimal. In plasma bioavailability studies, intact orlistat concentrations remain below the limit of quantitation (< 5 ng/mL) following standard single or multiple oral doses. Systemic exposure is therefore considered clinically negligible for its primary therapeutic outcome.
Metabolism of the small fraction absorbed occurs predominantly within the gastrointestinal wall, yielding two primary inactive metabolites designated M1 and M3. The principal route of elimination for unabsorbed drug is fecal excretion, accounting for approximately 97 percent of the administered dose. Renal excretion accounts for less than 2 percent of the cumulative dose. The terminal elimination half-life of the minor absorbed fraction ranges between 1 and 2 hours.
Compatibility with other medicines
Co-administration of Obelit with fat-soluble vitamins (vitamins A, D, E, and K) and beta-carotene can reduce their gastrointestinal absorption. A daily multivitamin supplement containing fat-soluble vitamins should be taken at least 2 hours before or after taking Obelit, such as at bedtime, to ensure adequate nutritional absorption.
Concomitant administration with cyclosporine requires temporal separation; cyclosporine should be administered 3 hours after or before Obelit to prevent reductions in cyclosporine blood concentration. Administration with levothyroxine may decrease thyroid hormone absorption, requiring an interval of at least 4 hours between administration and monitoring of thyroid function. Patients receiving warfarin or other oral anticoagulants require monitoring of coagulation parameters (INR) due to potential alterations in vitamin K absorption.
Adverse reactions
Gastrointestinal adverse events represent the primary category of side effects associated with Obelit therapy. These symptoms are directly attributable to the pharmacological mechanism of unabsorbed fat passing through the intestinal tract. Frequently observed events include oily spotting, flatus with discharge, fecal urgency, fatty or oily stool, oily evacuation, increased frequency of defecation, and fecal incontinence.
These gastrointestinal reactions are generally mild to moderate in intensity, tend to occur early during the initial phase of treatment, and decrease in frequency when dietary fat intake is maintained within recommended limits. Rare post-marketing reports include severe liver injury, pancreatitis, and acute oxalate nephropathy.
Important precautions
Obelit is contraindicated in patients with chronic malabsorption syndrome or cholestasis, as well as in individuals with known hypersensitivity to orlistat or any component of the formulation. Administration during pregnancy is contraindicated due to lack of benefit and potential risks to fetal development. Safety and efficacy in pediatric patients under 12 years of age have not been established.
Caution is warranted in patients with a history of hyperoxaluria or calcium oxalate nephrolithiasis, as increased urinary oxalate levels may develop. Patients with type 2 diabetes mellitus who achieve weight reduction during treatment may experience improved glycemic control, requiring adjustment of concomitant hypoglycemic medications such as sulfonylureas or insulin.
What to avoid while taking it
Patients taking Obelit should avoid consuming meals containing higher than recommended fat content. High-fat meals significantly increase the likelihood and severity of gastrointestinal adverse effects, such as abdominal cramping, oily spotting, and fecal urgency. While alcohol does not demonstrate a direct pharmacokinetic interaction with orlistat, alcoholic beverages contribute non-nutritional calories that may hinder weight management goals.
First days of treatment
During the initial days of Obelit administration, changes in bowel habits typically emerge within 24 to 48 hours following the first fat-containing meal. Unabsorbed dietary fat alters stool consistency and frequency. Strict adherence to dietary fat limits during the initial treatment phase helps moderate gastrointestinal symptoms as the body adapts to therapy.
If you skip a dose
If a dose of Obelit is missed during a meal, it may be taken up to one hour following that meal. If more than one hour has elapsed since meal completion, or if the meal contained no fat, the missed dose should be omitted entirely. The normal schedule should resume with the next planned meal. Patients should not double the dose to make up for a missed capsule.
Storage and expiration
Obelit capsules should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Protect the medication from heat, light, and moisture by keeping the container tightly closed. Store out of reach of children. Product that has exceeded its printed expiration date should be safely discarded according to standard disposal practices.
Common questions
Is Obelit effective if taken with a completely fat-free meal?
If a meal contains no dietary fat, administering Obelit provides no clinical benefit because the target enzymes require dietary triglycerides to manifest pharmacological activity. Under such circumstances, the dose should be omitted.
How does Obelit affect oral contraceptive efficacy?
Orlistat does not interact directly with systemic hormone levels. However, if severe diarrhea occurs as a gastrointestinal side effect, the absorption of oral contraceptives may be reduced, and supplementary non-hormonal contraceptive methods should be considered.
Is routine laboratory monitoring required during therapy?
Laboratory testing may be indicated depending on baseline patient health. Monitoring of fat-soluble vitamin levels, thyroid function (if taking levothyroxine), or INR parameters (if taking warfarin) may be performed as clinically appropriate.
Does Obelit alter central nervous system function or suppress appetite?
No. Obelit acts locally within the gastrointestinal lumen and does not produce central nervous system stimulation, systemic appetite suppression, or sympathomimetic effects.
What symptoms indicate a need for immediate medical evaluation?
If symptoms suggestive of liver dysfunction appear–such as yellowing of the skin or eyes (jaundice), dark urine, severe right upper abdominal pain, or persistent nausea–the medication should be discontinued and clinical advice sought immediately.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
60 mg ,120 mg |
|---|---|
| Package |
10 caps ,30 caps ,60 caps ,90 caps ,120 caps ,180 caps |
| Ενεργός Ουσία |
Related products
Alli
$ 41,00 – $ 317,00Price range: $ 41,00 through $ 317,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Astralean
$ 49,00 – $ 670,00Price range: $ 49,00 through $ 670,00
Active substance: Clenbuterol
More Details
This product has multiple variants. The options may be chosen on the product page
Karela
$ 63,00 – $ 79,00Price range: $ 63,00 through $ 79,00
Active substance: Normalized Karela Concentrate (Momordica charantia)
More Details
This product has multiple variants. The options may be chosen on the product page
Orligal
$ 13,00 – $ 42,00Price range: $ 13,00 through $ 42,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Orlistat
$ 59,00 – $ 455,00Price range: $ 59,00 through $ 455,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Rybelsus
$ 250,00 – $ 880,00Price range: $ 250,00 through $ 880,00
Active substance: Semaglutide
More Details
This product has multiple variants. The options may be chosen on the product page
Slim Trim Active
$ 54,00 – $ 145,00Price range: $ 54,00 through $ 145,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Slimonil
$ 53,00 – $ 76,00Price range: $ 53,00 through $ 76,00
More Details
This product has multiple variants. The options may be chosen on the product page
